State Street Corp Day One Biopharmaceuticals, Inc. Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
A detailed history of State Street Corp transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 2,894,883 shares of DAWN stock, worth $38.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,894,883
Previous 3,380,098
14.36%
Holding current value
$38.4 Million
Previous $49.3 Million
3.09%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding DAWN
# of Institutions
148Shares Held
60MCall Options Held
47.7KPut Options Held
61.3K-
Atlas Venture Life Science Advisors, LLC6.43MShares$85.3 Million13.29% of portfolio
-
Black Rock Inc. New York, NY5.03MShares$66.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.77MShares$63.4 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.81MShares$50.5 Million0.02% of portfolio
-
Viking Global Investors LP2.56MShares$34 Million0.16% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $975M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...